Sernova announced today that it received approval for a protocol amendment in the trial of its Cell Pouch System for treating type 1 diabetes. London, Ontario-based Sernova designed its proprietary Cell Pouch System as an implantable and scalable medical device. It forms a natural environment in the body for the long-term survival and function of […]

Cardiovascular Systems (NSDQ:CSII) today posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The St. Paul, Minnesota-based heart device maker reported losses of $10.6 million, or -27¢ per share, on sales of $59.67 million for the three months ended September 30 for a sales gain of 2.23% compared with Q1 […]

https://www.investing.com/news/pro/atricure-inc-pt-lowered-to-52-at-jpmorgan-432SI-2929450

AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief…

Keysight Technologies, Inc., a technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, announced that it is first to gain Global Certification Forum (GCF) validation of a 5G location-based services (LBS) Assisted Galileo (A-Galileo) test case by combining 5G new radio (NR) and global navigation…

Hatco Corporation, headquartered in Milwaukee, Wis., announced the purchase of Food Warming Equipment Company Inc. (FWE) on Oct. 31. FWE is a manufacturer specializing in heated holding cabinets, cook-and-hold ovens, smokers, refrigerated cabinets, transport carts and more, with locations in Crystal Lake, Illinois and Portland, Tenn. “Like Hatco, FWE has been serving its customers for…

Littelfuse, Inc. announced the new SMTOAK2 TVS Diode Series. Many of today’s high-power, high surge rating TVS diodes are only available in axial leaded packages. The compact, 2 kA 8/20 μs rated, surface-mount package SMTOAK2 TVS Diode Series allows electronics designers to achieve a more robust transient voltage, overvoltage protection, and lightning protection system while […]

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2022 financial results. “We are proud to share another quarter of strong commercial execution across our business, with excellent EnCompass traction following our launch earlier this year, increasing EPi-Sense® revenue and accounts, and ongoing

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2022 financial results on Tuesday, November 1, 2022. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, November 1, 2022, to discuss its third quarter 2022 financial results. To access the webcas